Skip to main content

Drug Shortages - June 2015

RheumNow is committed to reporting safety issues in our monthly Drug Safety Bulletins. Each month we will update you with reports of new, ongoing and resolved Drug Shortages that will affect the practicing rheumatologist. If you have suggestions or information about specific drug shortages or drug safety issues please email us at: info@rheumnow.com .

Reported Drug Shortages as of June 25, 2015

Drug Shortage

Reason for shortage

Estimated Availability

Acetaminophen #3 (300/30 mg codeine)

Market conditions

Mid to Late July 2015

Azathioprine injectable (100 mg vials)

Product not available. Previous maker bought out. No plans to make or promote IV AZA.

Unknown (oral AZA unaffected by shortage of IV AZA)

Azathioprine tablets (50 mg)

Problems obtaining active ingredient; on back order.

Late June 2015

Chloroquine tablets (250, 500 mg)

Two makers D/C making chloroquine tablets. Another has shortage due to 3rd party supply issues.

Unknown; product on long term backorder

Dexamethasone injection (4mg/ml)

Manufacturing delays, demand issues

Most companies have DEX on backorder; one company plans delivery mid June 2015

Epinephrine injection

Product discontinuations, hortage is due to increased demand.

Late June or early July 2015

Hydroxychloroquine tablets (200 mg)

Company buy-outs, regulatory issues, increased demand

HCQ back order; possibly mid July 2015

Ketorolac injection (15, 30, 60mg/ml)

Back ordered, increase demand

Late June 2015

Leflunomide (10 mg, 20 mg)

Trouble obtaining active ingredient

Mid August 2015

Lidocaine injection, 1%, 2% (2 ml, 5 ml, 10 ml vials)

Manufacturing delays, increased demand

Late May 2015

Methotrexate injection 25 mg/ml (2ml, 10ml, 40 ml vials)

Fewer makers, back orders, manufacturing delays. 2 companies (West-Ward, Sandoz) discontinued making 2ml and 10ml vials

Uncertain, possibly late June 2015. Mylan “on back order with no estimated release date”.

Pantoprazole tablets (20 mg, 40 mg)

Fewer makers, increased demand

On back order with no estimated release date

Tacrolimus tablets (0.5, 1.0, 5 mg)

Fewer makers, manufacturing delays

Unknown; intermittent back order

Source: http://www.ashp.org/DrugShortages/Current http://www.accessdata.fda.gov/scripts/drugshortages/default.cfm

RESOLVED Shortages: Colchicine, Cyclosporine, DTaP vaccine, Cyclophosphamide injection

ADD THE FIRST COMMENT

If you are a health practitioner, you may to comment.

Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.

Disclosures
The author has no conflicts of interest to disclose related to this subject